search
Back to results

Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

Primary Purpose

Wound Healing, Burns

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Healthy volunteers
Burn volunteers
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wound Healing focused on measuring Wound Healing, Burns, HIF-1, CAC

Eligibility Criteria

14 Years - 75 Years (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Recruitment of patients at the Johns Hopkins Regional Burn Center for study will be based upon the following clinical criteria:

  • Second degree scald burn of 10 cm2
  • Age between 14 to 75 years
  • Burn area equal or less than 95% of Burn Surface Area (BSA)
  • Body temperature between 98.5 and 101 degree F
  • Informed consent for enrolment into study
  • Spanish speaking patients will be included when we have a Spanish consent form available.

Exclusion Criteria:

  • First and third degree burn wounds
  • Hemodynamic instability (SBP below 100, Heart Rate (HR) over 100, urine output less than 30 ml/hour
  • Area of burn over 20% of BSA
  • Hypothermia T<98.5 or Hyperthermia T>101 degree F
  • Urine output less than 30 ml/hour
  • Serum albumin less than 3 mg/ml.
  • Subjects weighing less than 50 kg.

Sites / Locations

  • Johns Hopkins Bayview Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Sham Comparator

Active Comparator

Arm Label

Healthy volunteers

Burn volunteer

Arm Description

Healthy volunteers with no burn wounds Volunteers donate blood that will be studied in comparison to patients who have sustained burns. The circulating "bone marrow stem cells" will be counted and compared to the levels in burn patients. Six 12 ml tubes will be taken for the study. You will not be compensated. But you will be helping to advance science if you join the study.

To recruit burn wound patients with defined clinical criteria for study. A second-degree burn of at least 10 cm2 to up to 95% BSA; age = 14-75 years; BP > 100 mm Hg systolic; heart rate < 100 beats/minute; urine output > 30 ml/hour; area of burn < 20% of BSA; body temperature = 98.5-101 degrees Fahrenheit; serum albumin > 3 mg/ml; and informed consent. We will also obtain a history regarding the presence or absence of risk factors that may affect CAC numbers: hypertension > 1 year; smoking > 2 pack-years or within the last year; diabetes mellitus; and family history of premature coronary artery disease (men < 55 and women < 65 years of age).Six 12 ml tubes will be taken at 5 time points

Outcomes

Primary Outcome Measures

The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Secondary Outcome Measures

Full Information

First Posted
November 21, 2008
Last Updated
August 31, 2017
Sponsor
Johns Hopkins University
Collaborators
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00796627
Brief Title
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
Official Title
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Terminated
Why Stopped
unable to recruit enough patients
Study Start Date
December 2006 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This research is being done to increase knowledge about wound healing and different factors that may affect healing in burn patients.
Detailed Description
Burn injuries represent a major public health problem, requiring medical attention for more than one million Americans annually. Despite therapeutic advances, non-healing burn wounds and excessive scarring still result in significant long term physical and psychosocial morbidity. In this study we propose to perform clinical and research to study the role of circulating angiogenic cells (CAC) in promoting burn wound healing. CAC's have been shown to contribute to vascularization and tissue repair in a number of animal models of tissue injury ischemia and mobilization of CACs into the peripheral blood has been demonstrated in burn wound patients. We hypothesize that primary healing of burn wounds is dependent on repair of damaged vasculature, and that bone marrow derived stem cells, circulating angiogenic cells (CAC), play a critical role in the healing process. Furthermore we propose that the transcription factor Hypoxia Inducible Factor 1 alpha (HIF 1 alpha) through production of peptide products of its downstream target genes directs the "homing" of CAC's to the wound where they participate in healing events. The first aim of this study is to correlate mobilization of CAC's into the blood stream with the success of burn wound healing. CAC's have been shown to contribute to vascularization and tissue repair in a number of studies. The relationship between mobilization of CAC's and burn wound healing has not been examined. In addition to surveying CAC numbers in the peripheral blood, we will assay levels of the putative mediators of CAC mobilization: Vascular Endothelial Growth Factor (VEGF), Placenta Growth Factor (PLGF), and Stromal Cell-Derived Factor (SDF-1). We hypothesize that individuals who are able to mount a large and sustained mobilization of CAC's into the peripheral blood from the bone marrow, will be more likely to heal the injured vasculature and go on to primary healing. Individuals with an inadequate mobilization of CAC's will fail to repair the damaged vasculature in the wound and proceed to necrosis and "conversion" to third degree, necrotic burn wounds.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Healing, Burns
Keywords
Wound Healing, Burns, HIF-1, CAC

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Open Label
Allocation
Non-Randomized
Enrollment
41 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Healthy volunteers
Arm Type
Sham Comparator
Arm Description
Healthy volunteers with no burn wounds Volunteers donate blood that will be studied in comparison to patients who have sustained burns. The circulating "bone marrow stem cells" will be counted and compared to the levels in burn patients. Six 12 ml tubes will be taken for the study. You will not be compensated. But you will be helping to advance science if you join the study.
Arm Title
Burn volunteer
Arm Type
Active Comparator
Arm Description
To recruit burn wound patients with defined clinical criteria for study. A second-degree burn of at least 10 cm2 to up to 95% BSA; age = 14-75 years; BP > 100 mm Hg systolic; heart rate < 100 beats/minute; urine output > 30 ml/hour; area of burn < 20% of BSA; body temperature = 98.5-101 degrees Fahrenheit; serum albumin > 3 mg/ml; and informed consent. We will also obtain a history regarding the presence or absence of risk factors that may affect CAC numbers: hypertension > 1 year; smoking > 2 pack-years or within the last year; diabetes mellitus; and family history of premature coronary artery disease (men < 55 and women < 65 years of age).Six 12 ml tubes will be taken at 5 time points
Intervention Type
Genetic
Intervention Name(s)
Healthy volunteers
Intervention Description
Comparison of healthy volunteers to burn wounded volunteers
Intervention Type
Other
Intervention Name(s)
Burn volunteers
Other Intervention Name(s)
Burn wounds
Intervention Description
Comparison of burn wounded volunteers to healthy volunteers
Primary Outcome Measure Information:
Title
The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury
Description
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Time Frame
baseline
Title
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury
Description
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Time Frame
0 to 24 hours post-operative
Title
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury
Description
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Time Frame
49 to 72 hours post-operative
Title
Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury
Description
Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.
Time Frame
73 hours to 6 weeks post-operative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Recruitment of patients at the Johns Hopkins Regional Burn Center for study will be based upon the following clinical criteria: Second degree scald burn of 10 cm2 Age between 14 to 75 years Burn area equal or less than 95% of Burn Surface Area (BSA) Body temperature between 98.5 and 101 degree F Informed consent for enrolment into study Spanish speaking patients will be included when we have a Spanish consent form available. Exclusion Criteria: First and third degree burn wounds Hemodynamic instability (SBP below 100, Heart Rate (HR) over 100, urine output less than 30 ml/hour Area of burn over 20% of BSA Hypothermia T<98.5 or Hyperthermia T>101 degree F Urine output less than 30 ml/hour Serum albumin less than 3 mg/ml. Subjects weighing less than 50 kg.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Harmon, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Johns Hopkins Bayview Medical Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
20231626
Citation
Zhang X, Wei X, Liu L, Marti GP, Ghanamah MS, Arshad MJ, Strom L, Spence R, Jeng J, Milner S, Harmon JW, Semenza GL. Association of increasing burn severity in mice with delayed mobilization of circulating angiogenic cells. Arch Surg. 2010 Mar;145(3):259-66. doi: 10.1001/archsurg.2009.285.
Results Reference
derived

Learn more about this trial

Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

We'll reach out to this number within 24 hrs